Absorption: Well absorbed from IM sites; absorbed slowly.
Distribution: Crosses the placenta.
Protein Binding: 98%.
Half-Life: 8 days.
| ROUTE | ONSET | PEAK | DURATION |
|---|---|---|---|
| IM | unknown | unknown | 2–4 wk |
‡Response is highly variable among individuals; may take mo.
Contraindicated in:
Use Cautiously in:
EENT: deepening of voice
CV: MI, STROKE, VENOUS THROMBOEMBOLISM, edema
GI: cholestatic jaundice, drug-induced hepatitis, liver function test elevation, nausea, vomiting
GU: change in libido, erectile dysfunction, priapism, prostatic enlargement
Endo: gynecomastia, hirsutism, oligospermia, hypercholesterolemia
F and E: hypercalcemia, hyperkalemia, hyperphosphatemia
Derm: male pattern baldness
Local: pain at injection site
Drug-drug:
Lab Test Considerations:
NDC Code